Explore 3 Stock Ideas & Industry Insights Download Free Report

News

What Should Investors Expect When Precision Optics (NASDAQ:POCI) Reports Q1 Fiscal 2027 Results on November 16, 2026?

In the fourth quarter of fiscal 2026, ended June 30, 2026, revenue was USD 8.8 million, up about 42% from a year earlier, gross margin was 25.3% and the net loss was USD 0.1 million, or USD 0.01 per share. For fiscal 2026 the …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Veritone, Inc. (NASDAQ:VERI) Reports Q3 2026 Results on November 16, 2026?

The second quarter GAAP net loss was USD 22.2 million and the non-GAAP net loss was USD 10.0 million, with an operating loss of USD 22.1 million andDepreciationand amortization of USD 5.8 million. Management reported that the first phase of cost reductions delivered USD …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Oncolytics Biotech Inc. (NASDAQ:ONCY) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Oncolytics Biotech Inc. (NASDAQ:ONCY)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Antalpha Platform Holding (NASDAQ:ANTA) Reports Q3 2026 Results on November 16, 2026?

Key Highlights12.2 million USD is theRevenueAntalpha PlatformHolding Company(NASDAQ:ANTA) reported for the second quarter of 2026, down 28% from a year earlier, led by USD 7.7 million of technology financing fees.10 million to USD 12 million is the revenue range management guided for the third …

Vinay Lochav | 13 November 2026

What Should Investors Expect When GameSquare Holdings, Inc. (NASDAQ:GAME) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for GameSquare Holdings, Inc. (NASDAQ:GAME)

Vinay Lochav | 13 November 2026

What Should Investors Expect When 374Water Inc. (NASDAQ:SCWO) Reports Q3 2026 Results on November 16, 2026?

Second quarterGross Profitwas USD 1.98 million, an 87% margin, compared with a gross deficit of about USD 0.3 million, or about -46%, in the second quarter of 2025. Operating expenses fell to USD 3.6 million from USD 4.3 million, and management cited annualized operating …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Xtant Medical Holdings (NYSEAMERICAN:XTNT) Reports Q3 2026 Results on November 16, 2026?

The Rationale: Last Reported Quarter and Management Outlook for Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT)

Vinay Lochav | 13 November 2026

What Should Investors Expect When Phunware, Inc. (NASDAQ:PHUN) Reports Q3 2026 Results on November 16, 2026?

Second quarter gross profit was USD 551 thousand at a 69.0% margin, versus USD 190 thousand and 41.8% a year earlier. The operating loss was USD 6.0 million versus USD 4.3 million, the net loss was USD 5.2 million versus USD 3.1 million, and …

Vinay Lochav | 13 November 2026

What Should Investors Expect When OS Therapies (NYSEAMERICAN:OSTX) Reports Q3 2026 Results on November 16, 2026?

In the second quarter of 2026 management reported that 2.5-year overall survival was 75% versus 47%, and that the European Medicines Agency and Australia'sTherapeutic Goods Administrationaligned on 3-year overall survival and biomarker data as approvable measures. Phase 3 design alignment was reached among the …

Vinay Lochav | 13 November 2026

What Should Investors Expect When Rapid Micro Biosystems (NASDAQ:RPID) Reports Q3 2026 Results on November 16, 2026?

Second quarter gross margin was USD 1.2 million, or 15.0%, versus 3.8% a year earlier, while operating expenses rose 8.9% to USD 13.5 million. Adjusted EBITDA loss was USD 10.3 million versus USD 10.1 million. The company placed 4 Growth Direct systems and completed …

Vinay Lochav | 13 November 2026
Support

Hi! How can we help you today?

Loading…